Tag: Novamind - Page 2 - Psychedelic Alpha

Read more about the article Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada

Post published:July 31, 2020
Post category:Press Release

Read more about the article Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Post published:July 30, 2020
Post category:Press Release

Read more about the article Novamind Announces Closing of Oversubscribed Private Placement

Novamind Announces Closing of Oversubscribed Private Placement

Post published:July 14, 2020
Post category:Press Release

Read more about the article Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Synthesis Raises US$2.75M to Develop End-to-End Professional Platform for Psychedelic Wellness & Therapy

Post published:July 7, 2020
Post category:Press Release

Read more about the article Hinterland to Acquire Novamind Ventures Inc.

Hinterland to Acquire Novamind Ventures Inc.

Post published:July 6, 2020
Post category:Press Release

Read more about the article Novamind and Buzz Capital Announce Qualifying Transaction

Novamind and Buzz Capital Announce Qualifying Transaction

Post published:May 19, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.